Shanghai Shen Lian Biomedical Corporation (SHA:688098)

SHA:688098 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	74.27	146.21	44.98	52.74	44.21	114.61
Trading Asset Securities	60.4	43.81	162.38	305.12	424.08	472.45
Cash & Short-Term Investments	134.66	190.02	207.35	357.87	468.29	587.07
Cash Growth	-18.91%	-8.36%	-42.06%	-23.58%	-20.23%	-14.67%
Accounts Receivable	325.45	261.4	273.97	222.76	154.61	131.31
Other Receivables	4.06	3.17	3.09	6.82	5.99	3.63
Receivables	329.51	264.57	277.06	229.57	160.61	134.94
Inventory	80.96	95.1	111.79	115.33	103.42	71.17
Other Current Assets	2.35	1.14	2.09	2.74	1.14	0.68
Total Current Assets	547.48	550.83	598.29	705.5	733.46	793.86
Property, Plant & Equipment	813.13	811.19	823.31	776.66	768.55	642.76
Long-Term Investments	28.12	6.58	1.59	1.58	1.57	1.57
Other Intangible Assets	124.68	102.66	93.6	53.12	32.66	33.23
Long-Term Deferred Tax Assets	12.65	13.26	5.14	6.5	7.08	8.39
Long-Term Deferred Charges	13.43	33.18	42.35	42.17	35.52	1.88
Other Long-Term Assets	20.86	36.41	29.72	19.56	19.62	32.78
Total Assets	1,560	1,554	1,594	1,605	1,598	1,514
Accounts Payable	11.38	5.44	5.14	8.86	11.33	7.54
Accrued Expenses	10.06	57.82	42.8	48.37	58.72	55.7
Short-Term Debt	13.45	14.01	-	-	-	-
Current Portion of Leases	0.47	0.48	0.33	0.14	0.13	-
Current Income Taxes Payable	3.69	-	0.23	7.58	5.09	1.01
Current Unearned Revenue	12.15	19.59	6.65	10.61	8.92	14.58
Other Current Liabilities	76.92	18.86	21.35	21.66	29.33	27.05
Total Current Liabilities	128.13	116.2	76.5	97.22	113.53	105.87
Long-Term Leases	1.26	1.01	0.92	0.31	0.38	-
Long-Term Unearned Revenue	9.6	11.08	9.49	10.36	11.3	12.22
Long-Term Deferred Tax Liabilities	0.43	0.21	0.02	0.32	0.27	0.11
Total Liabilities	139.42	128.5	86.93	108.21	125.48	118.2
Common Stock	410.64	410.64	410.64	410.64	410.64	409.7
Additional Paid-In Capital	539.23	539.23	539.23	546.04	552.18	539.92
Retained Earnings	480.02	479.74	538.85	540.19	516.05	446.79
Treasury Stock	-20	-18.32	-	-	-	-
Total Common Equity	1,410	1,411	1,489	1,497	1,479	1,396
Minority Interest	11.03	14.33	18.34	-	-5.89	-0.15
Shareholders' Equity	1,421	1,426	1,507	1,497	1,473	1,396
Total Liabilities & Equity	1,560	1,554	1,594	1,605	1,598	1,514
Total Debt	15.17	15.49	1.25	0.45	0.51	-
Net Cash (Debt)	119.49	174.53	206.1	357.42	467.78	587.07
Net Cash Growth	-27.28%	-15.32%	-42.34%	-23.59%	-20.32%	-10.78%
Net Cash Per Share	0.29	0.43	0.52	0.88	1.15	1.41
Filing Date Shares Outstanding	410.64	407.53	410.64	410.64	379.56	409.7
Total Common Shares Outstanding	410.64	407.53	410.64	410.64	379.56	409.7
Working Capital	419.35	434.63	521.79	608.29	619.93	687.99
Book Value Per Share	3.43	3.46	3.63	3.65	3.90	3.41
Tangible Book Value	1,285	1,309	1,395	1,444	1,446	1,363
Tangible Book Value Per Share	3.13	3.21	3.40	3.52	3.81	3.33
Buildings	-	343.74	318.94	298.9	285.68	225.1
Machinery	-	600.61	595.91	577.97	495.93	436.53
Construction In Progress	-	177.87	163.44	98.95	133.78	92.16

Source: S&P Global Market Intelligence. Standard template. Financial Sources.